These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 21122807

  • 1. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
    Vilà L, Rebollo A, Ađalsteisson GS, Alegret M, Merlos M, Roglans N, Laguna JC.
    Toxicol Appl Pharmacol; 2011 Feb 15; 251(1):32-40. PubMed ID: 21122807
    [Abstract] [Full Text] [Related]

  • 2. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.
    Roglans N, Sanguino E, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM.
    J Pharmacol Exp Ther; 2002 Jul 15; 302(1):232-9. PubMed ID: 12065722
    [Abstract] [Full Text] [Related]

  • 3. Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A.
    Rodríguez-Calvo R, Barroso E, Serrano L, Coll T, Sánchez RM, Merlos M, Palomer X, Laguna JC, Vázquez-Carrera M.
    Hepatology; 2009 Jan 15; 49(1):106-15. PubMed ID: 19053045
    [Abstract] [Full Text] [Related]

  • 4. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.
    Ji G, Zhao X, Leng L, Liu P, Jiang Z.
    Lipids Health Dis; 2011 Jan 26; 10():23. PubMed ID: 21269482
    [Abstract] [Full Text] [Related]

  • 5. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress.
    Baena M, Sangüesa G, Hutter N, Sánchez RM, Roglans N, Laguna JC, Alegret M.
    Biochim Biophys Acta; 2015 Feb 26; 1851(2):107-16. PubMed ID: 25463011
    [Abstract] [Full Text] [Related]

  • 6. Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
    Funatsu T, Kakuta H, Takasu T, Miyata K.
    Eur J Pharmacol; 2002 Nov 29; 455(2-3):161-7. PubMed ID: 12445582
    [Abstract] [Full Text] [Related]

  • 7. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, Teoh N.
    J Gastroenterol Hepatol; 2012 Aug 29; 27(8):1353-61. PubMed ID: 22432744
    [Abstract] [Full Text] [Related]

  • 8. Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose.
    Vilà L, Roglans N, Perna V, Sánchez RM, Vázquez-Carrera M, Alegret M, Laguna JC.
    J Nutr Biochem; 2011 Aug 29; 22(8):741-51. PubMed ID: 21115336
    [Abstract] [Full Text] [Related]

  • 9. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
    Mangaloglu L, Cheung RC, Van Iderstine SC, Taghibiglou C, Pontrelli L, Adeli K.
    Metabolism; 2002 Apr 29; 51(4):409-18. PubMed ID: 11912545
    [Abstract] [Full Text] [Related]

  • 10. Long-term fructose consumption prolongs hepatic stearoyl-CoA desaturase 1 activity independent of upstream regulation in rats.
    Liu L, Wang S, Yao L, Li JX, Ma P, Jiang LR, Ke DZ, Pan YQ, Wang JW.
    Biochem Biophys Res Commun; 2016 Oct 28; 479(4):643-648. PubMed ID: 27697525
    [Abstract] [Full Text] [Related]

  • 11. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
    Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ.
    Inflammation; 2008 Apr 28; 31(2):121-32. PubMed ID: 18302012
    [Abstract] [Full Text] [Related]

  • 12. Liquid fructose in pregnancy exacerbates fructose-induced dyslipidemia in adult female offspring.
    Rodríguez L, Panadero MI, Rodrigo S, Roglans N, Otero P, Álvarez-Millán JJ, Laguna JC, Bocos C.
    J Nutr Biochem; 2016 Jun 28; 32():115-22. PubMed ID: 27142744
    [Abstract] [Full Text] [Related]

  • 13. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX, Yu R, Xu MX, Li PQ, Fan CY, Li JM, Kong LD.
    Eur J Pharmacol; 2016 Jan 05; 770():154-64. PubMed ID: 26593707
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb 15; 306(4):G320-7. PubMed ID: 24356885
    [Abstract] [Full Text] [Related]

  • 15. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ, Shi L, Song GY, Zhang HF, Hu ZJ, Wang C, Zhang DH.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):89-95. PubMed ID: 23791610
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
    Moon JH, Kang SB, Park JS, Lee BW, Kang ES, Ahn CW, Lee HC, Cha BS.
    Metabolism; 2011 Jul 15; 60(7):930-40. PubMed ID: 20951395
    [Abstract] [Full Text] [Related]

  • 19. Chronic fructose intake does not induce liver steatosis and inflammation in female Sprague-Dawley rats, but causes hypertriglyceridemia related to decreased VLDL receptor expression.
    Sangüesa G, Montañés JC, Baena M, Sánchez RM, Roglans N, Alegret M, Laguna JC.
    Eur J Nutr; 2019 Apr 15; 58(3):1283-1297. PubMed ID: 29516226
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.